Pharmaceutical Industry

Page 87 of 100

MSMB Capital Management CIO Martin Shkreli
Health

This super-expensive drug is getting a $1 rival

By
October 23, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant short seller on pharmacy alliance: It’s the ‘turd in the punch bowl’

By
October 22, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

Valeant’s accounting problems: It gets worse

By
October 22, 2015
Big pharma won’t stay silent in drug pricing debate for long
Health

Big pharma won’t stay silent in drug pricing debate for long

By
October 22, 2015
New Reasearch Shows That Aspirin May Cut Breast Cancer Risk
Health

The world’s biggest clinical trial is for one of the cheapest drugs

By
October 22, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Forget the plunging stock price, here’s Valeant’s biggest problem

By
October 22, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health

Short-seller: Is Valeant the pharmaceutical Enron?

By
October 21, 2015
519891667
Health

Drug companies are paying huge sums to fast-track FDA approval

By
October 20, 2015
MSMB Capital Management CIO Martin Shkreli
Leadership

The face of high drug prices is trolling Bernie Sanders on Twitter

By
October 19, 2015
Marco Rubio
Leadership

Marco Rubio calls out high drug prices

By
October 19, 2015
Parkinson’s patients show improvement after taking cancer drug
Health

Parkinson’s patients show improvement after taking cancer drug

By
October 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

Valeant eases up on strategy to buy up ‘mispriced drugs’

By
October 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

Valeant beat expectations in 3Q thanks to U.S. skin business

By Reuters and Fortune Editors
October 19, 2015
Hillary Clinton in the first Democratic presidential debate in Las Vegas on Oct. 13
Commentary

Clinton’s big pharma takedown plan has some serious issues

By Chris Ford and Bethany Cianciolo
October 16, 2015
Democratic Candidates Attend New Hampshire Democratic Party Convention
Leadership

Bernie Sanders rejects drug price-raising CEO’s donation: ‘We don’t want his stinkin’ money’

By
October 16, 2015

Most Popular